UltraSight, a digital health company focused on AI-powered cardiac imaging, has teamed up with US-based medical equipment manufacturer EchoNous to advance cardiac ultrasound.

The collaboration aims to enable healthcare professionals to perform cardiac ultrasounds and help increase patient access to cardiac care.

It will integrate UltraSight’s real-time AI guidance software with EchoNous’ Kosmos handheld ultrasound device to enable chronic cardiac patient monitoring closer to patients.

The combined capabilities will help healthcare professionals with no prior sonography training to accurately conduct echocardiographic examinations.

According to UltraSight’s study results, which are the basis for its FDA submission, beginners using real-time AI guidance software can acquire diagnostic quality cardiac ultrasound images.

UltraSight said its real-time AI guidance software is currently under FDA 510(k) review.

UltraSight CEO Davidi Vortman said: “Empowering a greater number of healthcare professionals in more care settings to conduct cardiac ultrasound brings us one step closer to realising our vision of making cardiac care more equitable for patients around the world.

“We know that image quality is the key for achieving an accurate patient diagnosis. This is why we are thrilled to collaborate with EchoNous, which provides superior image quality and offers one of the most advanced handheld ultrasound systems available on the market.”

EchoNous unveiled its advanced Kosmos handheld ultrasound device in 2020 and has been improving the platform since then.

Its AI-powered Kosmos ultrasound system is said to deliver capabilities and image quality that is comparable to cart-based systems at a lower cost.

Through its collaboration with UltraSight, EchoNous will obtain complementary AI guidance capabilities that further enhance its Kosmos’ AI offering.

Together with EchoNous Kosmos, UltraSight’s underlying AI neural network predicts the position of the ultrasound probe relative to the heart based on the ultrasound video stream.

Also, it guides the user on manoeuvring the probe to capture diagnostic quality cardiac images at the point of care, which can then be read remotely.

The technology can improve access to optimised cardiac care and more cost-effective heart monitoring opportunities by separating the acquisition and interpretation of ultrasound images.

EchoNous CEO Graham Cox said: “UltraSight’s AI solution in conjunction with our own AI technology will help widespread use and adoption to provide Echocardiology exams in any location or setting.

“With this partnership, we will work toward offering remote clinicians the tools they need to make lifesaving diagnoses, cardiac monitoring and potentially improve cardiac care for patients in rural areas.”